Sangamo Therapeutics Inc (NASDAQ:SGMO)

18.15
Delayed Data
As of 4:00pm ET
 -0.90 / -4.72%
Today’s Change
4.05
Today|||52-Week Range
27.50
+10.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-16.6M-12.5M-12.4M-13.1M
 
 
 
 
 
Depreciation301.0K317.0K412.0K468.0K
 
 
 
 
 
Total Other Cash Flow2.9M1.9M1.8M1.9M
 
 
 
 
 
Funds From Operations-13.4M-10.3M-10.1M-10.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-333.0K-67.1M5.6M6.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-13.1M56.8M-15.7M-16.8M
 
 
 
 
 
 
InvestingIncrease In Investments-39.0M-120.2M-70.4M-22.7M
 
 
 
 
 
Decrease In Investments45.5M37.5M44.1M51.6M
 
 
 
 
 
Capital Expenditures-468.0K-1.7M-698.0K-878.0K
 
 
 
 
 
Other Investing - Uses0.000.000.00-3.5M
 
 
Net Cash Flow Investing6.1M-84.4M-27.1M24.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale3.4M78.9M2.8M13.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing------0.00--
Other Uses - Financing4.0K3.0K-7.0K654.0K
 
 
 
 
 
Net Cash Flow - Financing3.4M78.9M2.8M12.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-3.6M51.4M-39.9M19.9M